For citations:
Rumyantsev P.O., Borodavina E.V., Kutukova S.I., Vasilyeva E.B. Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice. Head and Neck Tumors (HNT). 2021;11(3):47-55. (In Russ.) https://doi.org/10.17650/2222-1468-2021-11-3-47-55
Email this article 